Literature DB >> 21935645

Clinical characteristics of adult patients with influenza-like illness hospitalized in general ward during Influenza A H1N1 pandemic 2009/2010.

B Pečavar1, K Nadrah, L Papst, V Ceč, T Kotar, M Matičič, J Meglič-Volkar, L Vidmar, B Beović.   

Abstract

OBJECTIVE: To investigate clinical and laboratory features of patients with Influenza A H1N1 virus infection hospitalized during 2009/2010 pandemic.
METHODS: Prospective observational study comparing clinical and laboratory characteristics of Influenza A H1N1 positive and negative patients with influenza-like illness (ILI).
RESULTS: From October 21, 2009 to February 14, 2010 196 ILI patients were admitted, of which 66 tested positive for Influenza A H1N1. The patients with H1N1 infection were younger (43 years vs. 65 years; P < 0.01), more patients were pregnant (P < 0.01), had allergies (P < 0.05) or, asthma (P < 0.01). H1N1 positive patients were more often febrile (91% vs. 72.9%; P < 0.01) and had a higher prevalence of headache (31.8% vs. 18.5%; P < 0.05). Lower values of C-reactive protein (88 pg/dl vs. 126 pg/dl; P < 0.01), procalcitonine (0.42 µg/l vs. 3.98 µg/l; P < 0.05), leukocyte count (7.4*10(9)/l vs. 11.7*10(9)/l; P < 0.01) and higher values of troponin (0.162 µ/l vs. 0.146 µg/l; P < 0.01) were found in H1N1 positive patients. More bacterial infections were found in H1N1 negative group (68.8% vs. 89.2%; P < 0.05).
CONCLUSIONS: In this study patients infected with Influenza A H1N1 differed from H1N1 negative ILI patients in several clinical and laboratory characteristics. The same was observed also by other investigators. The results of the study suggest some other specific features, such as a higher incidence of headache and higher values of troponin in Influenza A H1N1 infected patients.

Entities:  

Mesh:

Year:  2011        PMID: 21935645      PMCID: PMC7101784          DOI: 10.1007/s00508-011-0054-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  14 in total

1.  Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus.

Authors:  Vladimir Trifonov; Hossein Khiabanian; Raul Rabadan
Journal:  N Engl J Med       Date:  2009-05-27       Impact factor: 91.245

Review 2.  Swine flu and pregnancy.

Authors:  M Toal; K Agyeman-Duah; A Schwenk; W Yoong
Journal:  J Obstet Gynaecol       Date:  2010-02       Impact factor: 1.246

3.  Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.

Authors:  Alicia M Siston; Sonja A Rasmussen; Margaret A Honein; Alicia M Fry; Katherine Seib; William M Callaghan; Janice Louie; Timothy J Doyle; Molly Crockett; Ruth Lynfield; Zack Moore; Caleb Wiedeman; Madhu Anand; Laura Tabony; Carrie F Nielsen; Kirsten Waller; Shannon Page; Jeannie M Thompson; Catherine Avery; Chasisity Brown Springs; Timothy Jones; Jennifer L Williams; Kim Newsome; Lyn Finelli; Denise J Jamieson
Journal:  JAMA       Date:  2010-04-21       Impact factor: 56.272

4.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Bin Cao; Xing-Wang Li; Yu Mao; Jian Wang; Hong-Zhou Lu; Yu-Sheng Chen; Zong-An Liang; Lirong Liang; Su-Juan Zhang; Bin Zhang; Li Gu; Lian-He Lu; Da-Yan Wang; Chen Wang
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

5.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

6.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

7.  The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection.

Authors:  Kim Greaves; John S Oxford; Christopher P Price; Geraldine H Clarke; Tom Crake
Journal:  Arch Intern Med       Date:  2003-01-27

8.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis.

Authors:  Santiago Echevarría-Zuno; Juan Manuel Mejía-Aranguré; Alvaro J Mar-Obeso; Concepción Grajales-Muñiz; Eduardo Robles-Pérez; Margot González-León; Manuel Carlos Ortega-Alvarez; Cesar Gonzalez-Bonilla; Ramón Alberto Rascón-Pacheco; Víctor Hugo Borja-Aburto
Journal:  Lancet       Date:  2009-11-11       Impact factor: 79.321

9.  Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries.

Authors:  Nancy F Crum-Cianflone; Patrick J Blair; Dennis Faix; John Arnold; Sara Echols; Sterling S Sherman; John E Tueller; Tyler Warkentien; Gabriela Sanguineti; Mary Bavaro; Braden R Hale
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

10.  Severe 2009 H1N1 influenza in pregnant and postpartum women in California.

Authors:  Janice K Louie; Meileen Acosta; Denise J Jamieson; Margaret A Honein
Journal:  N Engl J Med       Date:  2009-12-23       Impact factor: 91.245

View more
  3 in total

Review 1.  The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.

Authors:  Chandini Raina MacIntyre; Abrar Ahmad Chughtai; Michelle Barnes; Iman Ridda; Holly Seale; Renin Toms; Anita Heywood
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

2.  Cardiac troponin elevation in patients with influenza virus infections.

Authors:  Giuseppe Lippi; Fabian Sanchis-Gomar
Journal:  Biomed J       Date:  2020-06-10       Impact factor: 4.910

3.  Influenza A(H1N1)pdm09 and cystic fibrosis lung disease: a systematic meta-analysis.

Authors:  Hanna Renk; Nicolas Regamey; Dominik Hartl
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.